证券代码：603193 证券简称：润本股份 公告编号：2025-021 润本生物技术股份有限公司 第二届董事会第八次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 润本生物技术股份有限公司（以下简称"公司"）第二届董事会第八次会议 于 2025 年 5 月 6 日在公司会议室以通讯的方式召开。会议通知已于 2025 年 4 月 30 日通过书面文件、电子邮件的方式送达各位董事。本次会议应出席董事 5 人， 实际出席董事 5 人，各位董事以通讯形式参与本次会议。董事长赵贵钦先生为 会议主持人，公司监事及高级管理人员列席会议。本次会议的召集、召开和表决 程序符合《公司法》等有关法律、行政法规、部门规章、规范性文件和《公司章 程》的规定。 二、董事会会议审议情况 经与会董事认真审议，会议形成了如下决议： 2024 年，公司已率先竞得位于中新广州知识城国际生物医药创新园，凤亨 一路以北，凤亨二路以南，康联三路以西 ZSCB-E3-3 地块，面积约 3.2953 万 平方米的国有建设用地使用权，并于 ...

Investment Rating - The investment rating for the company is "Buy" [6] Core Views - The company's performance met expectations, with a revenue increase of 28% in 2024 and a net profit increase of 33%, driven by product expansion and channel diversification [1][5] - In Q1 2025, revenue grew by 44% and net profit by 25%, indicating strong growth momentum [1] - The company is focusing on product upgrades and channel expansion, with significant growth in online sales, particularly through platforms like Douyin [4][5] Summary by Sections Performance Overview - In 2024, the company achieved a revenue of 1.32 billion (up 28%) and a net profit of 300 million (up 33%) [1] - For Q1 2025, revenue reached 240 million (up 44%) and net profit was 40 million (up 25%) [1] Product Development - The company has seen significant success in its product upgrades, with a gross margin of 58.2% in 2024 and a net margin of 22.8% [2] - In Q1 2025, the gross margin was 57.7%, while the net margin decreased to 18.4% due to financial expenses and government subsidies [2] Market Segmentation - In Q1 2025, the baby care segment accounted for 77% of total sales, up 9 percentage points, with a notable increase in average selling prices driven by high-ticket new products [3] Sales Channels - Online sales saw a remarkable growth of 80% in Q1 2025, with significant contributions from platforms like Douyin, Tmall, and JD [4] - The company has expanded its offline presence by entering new channels such as Pang Dong Lai and Yonghui [4] Research and Development - The company is committed to rapid product iteration, with new launches in sunscreen and youth care products expected in 2025 [5] - The introduction of bundled product offerings is aimed at increasing sales of complementary items [5] Financial Forecast - The company is projected to achieve revenues of 1.71 billion, 2.14 billion, and 2.67 billion in 2025, 2026, and 2027 respectively, with corresponding net profits of 390 million, 487 million, and 605 million [5][10]

Summary of the Conference Call Records Industry Overview - The beauty and personal care industry is experiencing an increase in penetration rates and rising prices, showing stronger growth compared to traditional food and beverage sectors, leading new consumption trends [1][7] - Domestic brands are rapidly rising in the beauty and personal care market, replacing foreign brands, particularly Japanese and Korean brands, which are showing significant declines [1][3] Key Financial Performance - **Personal Care Segment**: - 2024 revenue growth of 19% and net profit growth of 25% - Q1 2025 revenue growth of 29% and profit growth of 13%, driven by product innovation and Douyin channel [1][6] - **Medical Aesthetics Segment**: - 2024 revenue growth of 16% and net profit growth of 22% - Q1 2025 revenue and profit remained flat, with significant internal differentiation [1][9] - **Cosmetics Industry**: - 2024 revenue growth of 11% and net profit decline of 9% (11% growth after excluding anomalies) - Some companies like Juzhi Biotechnology and Mao Ge Ping performed exceptionally well [1][10] Channel Performance - Douyin channel is noted for its dual role in marketing and sales, with high initial costs but potential for improved profitability as brand influence expands to other channels [4][8] - In April 2025, beauty brands on Douyin showed strong performance, with several brands achieving over 100% growth [11] Company-Specific Insights - **Ruo Yuchen**: - Q1 2025 revenue and profit growth exceeded 200% for its free brand and over 150% for its household cleaning brand [12] - **Deng Kang Oral Care**: - Q1 2025 revenue and profit growth of 15%-20%, with online channels showing over 200% growth [14] - **Polaire**: - Q1 2025 saw unexpected profit growth due to improved gross margins and optimized sales expenses [16] - **Mao Ge Ping**: - April 2025 Douyin channel growth of over 30% [17] - **Perfect Bio**: - Q1 2025 revenue growth of 28% and net profit close to 30% [18] - **Runben**: - Q1 2025 revenue growth of 44%, with a focus on new product launches [19] Market Trends and Investment Recommendations - The beauty and personal care sector is expected to continue leading new consumption trends, with investment strategies focusing on companies with strong innovation capabilities and those showing positive changes [1][7][26] - Recommended stocks include Ruo Yuchen, Deng Kang Oral Care, and Runben in the personal care segment, and high-end domestic brands like Mao Ge Ping and companies in the collagen segment like Juzhi Biotechnology [26] Additional Insights - The beauty and personal care sector is more sensitive to product demand, innovation, and channel changes compared to other consumer goods, providing a natural premium and innovation potential [24] - The overall market for personal care, beauty, and medical aesthetics is expected to show strong growth, driven by product innovation and structural opportunities [25]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Viewpoints - The retail sector is experiencing continuous operational pressure, with a focus on high-prosperity quality companies [4][24] - The overall revenue for the retail industry in 2024 and Q1 2025 decreased by 1.8% and 13.3% year-on-year, respectively, while the net profit attributable to the parent company decreased by 20.6% and 21.3% [4][24] - The report highlights the performance of various segments, including jewelry, beauty care, and cross-border e-commerce, with specific recommendations for investment opportunities [7][43] Summary by Relevant Sections Retail Market Overview - The retail industry index fell by 1.72% in the week of April 28 to April 30, 2025, underperforming the Shanghai Composite Index [6][15] - The beauty products segment showed the highest increase, with a weekly rise of 7.49% and a year-to-date increase of 12.66% [15][19] Industry Dynamics - The retail sector's financial reports indicate ongoing operational challenges, with a focus on high-prosperity segments [4][24] - The jewelry segment's revenue decreased by 4.9% in 2024 and 25.9% in Q1 2025, while the beauty care segment saw a revenue increase of 5.3% in 2024 but a slight decline of 1.7% in Q1 2025 [4][33][28] Investment Recommendations - Investment focus areas include traditional retail, jewelry, cosmetics, and medical aesthetics, with specific companies recommended for their growth potential [7][43] - Key recommended companies include Yonghui Supermarket, Aiyingshi, and various beauty brands such as Maogeping and Pulaia [7][46][44] Segment Performance - Cross-border e-commerce showed strong growth with a revenue increase of 31.9% in 2024 and 28.8% in Q1 2025, indicating a robust operational environment [4][38] - The beauty care segment is expected to maintain growth through differentiated products and strong brand positioning [28][44]

Investment Rating - The industry investment rating is optimistic (maintained) [1] Core Insights - Retail enterprises are under continuous operational pressure, with a focus on high-prosperity quality companies [4][24] - The overall revenue of the retail industry decreased by 1.8% in 2024 and 13.3% in Q1 2025, while the net profit attributable to the parent company decreased by 20.6% and 21.3% respectively [4][24] - The jewelry sector faced revenue declines of 4.9% in 2024 and 25.9% in Q1 2025, with net profit declines of 17.7% and 18.8% respectively [4][33] - The beauty care sector showed a revenue increase of 5.3% in 2024 but a slight decline of 1.7% in Q1 2025, with net profit declines of 17.5% and 21.7% respectively [4][28] - The cross-border e-commerce sector experienced significant growth, with revenue increases of 31.9% in 2024 and 28.8% in Q1 2025, while net profit showed a decline of 4.6% and an increase of 4.9% respectively [4][38] Summary by Sections Retail Market Overview - The retail industry index decreased by 1.72% in the week of April 28 to April 30, 2025, underperforming the Shanghai Composite Index [6][15] - The beauty products sector had the highest growth, with a weekly increase of 7.49% and a year-to-date increase of 12.66% [15][19] Industry Dynamics - The financial reports for 2024 and Q1 2025 indicate that retail enterprises are facing operational challenges, with a focus on high-prosperity sectors [4][24] - The jewelry sector is under pressure due to rising gold prices affecting consumer demand and operational challenges for weaker franchisees [4][33] - The beauty care sector remains relatively stable, with strong performance from differentiated beauty brands [4][28] Investment Recommendations - Focus on traditional retail companies that adapt to consumer trends, such as Yonghui Supermarket and Aiyingshi [7][43] - Highlight jewelry brands with differentiated product offerings, recommending brands like Laopu Gold and Chaohongji [7][43] - Emphasize domestic beauty brands that are expanding into high-prosperity segments, recommending brands like Maogeping and Shangmei [7][44] - Target upstream medical beauty product manufacturers with strong profitability, recommending companies like Aimeike and Kedi [7][44]

"小赛道"迎来大爆发！ 今 年以来，港股市场频现"消费牛股"，引发市场关注，事实上，A股市场同样涌现了一批"小赛道"高增长的个 股。4月29日，食品饮料赛道的盐津铺子、万辰集团，宠物经济赛道的中宠股份，美容护理赛道的百亚股份、 润本股份、锦波生物股价均创出历史新高。 去年四季度以来，不少公募基金产品投向这些高成长新兴消费公司，伴随这些公司股价的持续上涨，给基金净 值带来优异表现，如恒越匠心优选一年持有、申万菱信乐融一年持有、银华品质消费、海富通消费优选等年内 绩优消费主题基金收益回报均超20%。 渠道变革带来消费品公司业绩高增长 近期，去年四季度公募基金纷纷加仓的消费品赛道公司迎来股价持续上涨。 4月29日，食品饮料赛道的盐津铺子、万辰集团，宠物经济赛道的中宠股份，美容护理赛道的百亚股份、润本 股份、锦波生物股价均创出历史新高。 股价增长背后，是这些"小赛道"公司业绩的高增长。以零食品牌"好想来"母公司万辰集团为例，前一日，万辰 集团发布公告称，2025年第一季度，公司营业收入108.21亿元，同比增长124.02%，主要系公司量贩零食业务 持续发展，收入相应增加；归属净利润2.15亿元，同比提升3344.1 ...

Investment Rating - The report maintains a "Buy" rating for the company [3][5]. Core Insights - The company achieved a revenue of 1.318 billion yuan in 2024, representing a year-on-year growth of 27.61%, with a net profit of 300 million yuan, up 32.80% [1][9]. - The company has diversified its product offerings and expanded its sales channels, leading to sustained revenue growth [2][14]. - The company plans to distribute a cash dividend of 2.30 yuan per 10 shares (tax included) [1]. Financial Performance Summary - In 2024, the company reported a revenue of 1.318 billion yuan, with a breakdown by product: mosquito repellent products generated 439 million yuan (33.33% of total revenue, +35.39%), baby care products 690 million yuan (52.36%, +32.42%), essential oils 158 million yuan (11.97%, +7.88%), and other products 30 million yuan (2.27%, -25.51%) [2][10]. - The company’s online direct sales accounted for 58.72% of total revenue, amounting to 774 million yuan, with a growth of 24.84% [2][10]. - The company’s expense ratio increased to 31.57% in 2024, up 1.35 percentage points, primarily due to increased marketing and financial expenses [11][12]. Future Projections - Revenue projections for 2025-2027 are estimated at 1.711 billion yuan, 2.175 billion yuan, and 2.728 billion yuan, respectively, with net profits expected to be 392 million yuan, 496 million yuan, and 613 million yuan [3][14]. - The company’s projected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are 40x, 32x, and 26x, respectively [3][14].

Group 1 - The core viewpoint of the article highlights the resurgence of consumer stocks, particularly in sectors such as beauty, pets, and retail, with several companies reaching historical highs [1] - Notable companies that achieved record highs include Wancheng Group, Runben Co., Dongpeng Beverage, Yanjinpuzi, and Jinbo Biological, while Han Commercial Group, Laishen Tongling, Anzheng Fashion, and Meike Home reached their daily limit [1] - The Ministry of Commerce is collaborating with relevant departments to introduce several measures, including the 2025 work plan for improving service consumption and benefiting the public [1]

Investment Rating - The report maintains a "Recommended" rating for the company, indicating a potential upside of over 15% relative to the benchmark index [4]. Core Views - The company has demonstrated significant revenue growth, achieving a revenue of 1.318 billion yuan in 2024, a year-on-year increase of 27.61%, and a net profit of 300 million yuan, up 32.8% year-on-year [1]. - The company is actively strengthening its position in the baby care sector, with expectations for new product launches in 2025, particularly in the sunscreen category [4]. - The company is recognized as a leader in the mosquito repellent market and is expanding its baby care business to unlock further growth potential [4]. Revenue and Profitability - In 2024, the company achieved a gross margin of 58.17%, an increase of 1.83 percentage points year-on-year, with a net profit margin of 22.77%, up 0.89 percentage points year-on-year [3]. - For Q1 2025, the company reported a revenue of 240 million yuan, a 44% increase year-on-year, and a net profit of 44 million yuan, up 24.6% year-on-year [1][3]. Channel and Product Performance - Online direct sales generated 774 million yuan in revenue, a year-on-year increase of 24.84%, while the non-platform distributor channel saw a revenue increase of 39.64% to 347 million yuan [2]. - The mosquito repellent series achieved a revenue of 439 million yuan, up 35.39% year-on-year, while the baby care series generated 690 million yuan, a 32.42% increase [2]. Financial Forecasts - The company is projected to achieve a net profit of 399 million yuan in 2025, with a growth rate of 33.0%, and further growth to 506 million yuan in 2026 and 641 million yuan in 2027 [5][7]. - The expected price-to-earnings (PE) ratios for 2025, 2026, and 2027 are 36x, 28x, and 22x, respectively [5].

Core Insights - The company achieved robust growth in 2024 and Q1 2025, with revenue increasing by 28% and net profit by 33% in 2024, and Q1 2025 revenue up by 44% and net profit by 25% [1][2] Financial Performance - In 2024, the company reported revenue of 1.318 billion yuan, a year-on-year increase of 27.61%, and a net profit of 300 million yuan, up 32.8% [2] - Q4 2024 revenue was 281 million yuan, a 34.01% increase year-on-year, while net profit decreased by 13.28% [2] - Q1 2025 revenue reached 240 million yuan, a 44% increase year-on-year, with net profit at 44 million yuan, up 24.6% [2] Product Category Performance - In 2024, the core product categories showed strong growth, with mosquito repellent revenue at 439 million yuan (up 35.39%) and baby care revenue at 690 million yuan (up 32.42%) [3] - In Q1 2025, baby care revenue surged by 65.57% to 179 million yuan, while mosquito repellent revenue increased by 10.5% [3] Profitability and Cost Structure - The overall gross margin for 2024 was 58.17%, an increase of 1.82 percentage points, with a net profit margin of 22.77% [4] - In Q1 2025, the gross margin was 57.67%, with a net profit margin of 18.41%, reflecting a decrease of 2.87 percentage points [4] Future Outlook - The company is expected to continue its growth trajectory, with projected net profits of 389 million yuan, 481 million yuan, and 583 million yuan for 2025, 2026, and 2027, respectively, representing year-on-year growth rates of 30%, 24%, and 21% [1][4]